Passage Bio
NASDAQ: PASGPhiladelphia, US · Founded 2017 · Delaware corporation · 38 employees on LinkedIn · 1 known investors
Passage Bio is a biotechnology company developing treatments for central nervous system (CNS) diseases, with a focus on neurodegenerative conditions. It works on therapies for patients living or born with CNS diseases and their families.
Founders & leadership
TY
Tadataka YamadaNamed on SEC filing
SS
Stephen SquintoNamed on SEC filing
Board
PH
CG
Carl GordonBoard director
TS
Thomas Street Address 1 WoiwodeBoard director
SI
Saqib IslamBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$110M disclosed across 1 round · 2019
▶$110MraisedSep 2019 · 15 investors · Other Health CareRule 506(b)
▶$110MraisedSep 2019 · 15 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Patrick HeronDirector
- Carl GordonDirector
- Tadataka YamadaExecutive Officer, Director, Promoter
- Saqib IslamDirector
- Thomas Street Address 1 WoiwodeDirector
- Stephen SquintoExecutive Officer, Director
- Offering amount
- $110M
- Amount sold
- $110M
- First sale
- Aug 2019
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b, 3C, 3C.1
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 4
by search overlap
Seeking Alpha13 shared keywordsSeeking Alpha is a financial research platform offering stock analysis, market news, investment ideas, and quantitative ratings across asset classes, drawing on a large community of contributing analysts. It serves individual and professional investors seeking research and data-driven insight on stocks and markets.
Robinhood11 shared keywordsRobinhood is a financial trading platform that enables users to manage portfolios across stocks, ETFs, cryptocurrencies, options, futures, and prediction markets. The platform serves retail investors with low barriers to entry, offering portfolio management services and market insights.
TradingView11 shared keywordsTradingView is a charting platform and social network used by over 100 million traders and investors worldwide to analyze and trade across global financial markets. The platform provides tools for technical analysis, market data, and community collaboration for retail and institutional traders.
Oup11 shared keywordsOxford University Press publishes research, educational, and reference materials, including reports on reading and children's learning, and reference resources such as its dictionary "Word of the Day." It serves readers, educators, and learners across a wide range of subjects worldwide.
Companies competing with Passage Bio for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Passage Bio do?
- Passage Bio is a biotechnology company developing treatments for central nervous system (CNS) diseases, with a focus on neurodegenerative conditions. It works on therapies for patients living or born with CNS diseases and their families.
- Who are Passage Bio's investors?
- Passage Bio's investors include Frazier Life Sciences.
- How much funding has Passage Bio raised?
- Passage Bio has disclosed $110M raised across 1 round.
- Where is Passage Bio headquartered?
- Passage Bio is headquartered in Philadelphia, US.